A biotechnology start-up called Koniku Inc is trying to develop robots that could sniff out COVID-19 infections faster than conventional testing.
The technology fuses neurons with a silicon chip to create a “smell cyborg” capable of detecting scents ranging from explosives to pathogens.
Koniku’s first clinical trial began three weeks ago and would examine samples from patients tested for COVID-19 to compare how well the smell-bot detects the virus compared with traditional methods.
Photo: AFP
Small internal trials have already demonstrated that it can accurately detect the presence of influenza A.
“Our goal is to have a device that merges synthetic biology with silicon and maps all of the smells of human life on a global scale,” said Oshiorenoya Agabi, the San Rafael, California-based company’s chief executive officer and cofounder. “We should have a device in every home in America to screen for disease.”
Pathogens produce unique volatile organic compounds, scent-fingerprints of a sort, released by ailing cells. These signature smells are the same biological clues that allow dogs to sniff out dozens of diseases. Finland last month tested the ability of dogs to detect COVID-19 in a trial at Helsinki’s airport.
Some researchers have suggested that using dogs could be cheaper, faster and even potentially more effective in screening for the disease than methods including temperature checks, nasal swabs and saliva.
In July, German researchers showed that trained dogs were able to distinguish between saliva sampled from people infected with the virus and those who were not more than 90 percent of the time.
Koniku’s device, the Konikore, is slightly smaller than a frisbee and resembles a flying saucer. When the proteins in its chip bind to a scent it has been programmed to detect, cells amplify and process those signals with help from machine learning, and the device lights up.
In a field test in Alabama, it was able to detect explosives better than trained dogs. The test was conducted by law enforcement officials and aerospace giant Airbus SE, a Koniku investor and partner that has been working to roll out the technology in airports.
Koniku plans to conduct field trials with Airbus at Changi Airport in Singapore and then San Francisco International Airport later this year.
“If a dog can smell it, we can,” said Agabi, who described the Konikore as a “smell camera.”
He imagines the technology could be useful far beyond bombs and diseases.
For example, it could digitize the taste of food, allowing for the synthetic recreation of things like bacon, he said.
Koniku’s merger of biology and computing technology — often termed “wetware” — is a growing field. The company’s investors include Softbank Group Corp, Platform Capital Group, Halfcourt Ventures LLC, Changi Airport and Airbus’ venture capital arm.
Koniku has hired Treximo LLC, a biotech consulting and project management company, to conduct its trials for SARS-CoV-2. Trials for new devices are typically far faster and less intensive than those for new drugs.
Treximo said it expects it would be done with the necessary steps to apply for an emergency-use authorization with the US Food and Drug Administration in the first quarter of next year.
“We know this device can smell explosives, but can we have it pick up organic compounds in human breath to say yes or no does this person have SARS-CoV-2?” Treximo chief executive officer Michael Stomberg said. “It’s a game-changing device if it proves to be valid.”
The devices are to go on pre-sale for hardware developers this week.
After COVID-19, Agabi imagines the company pursuing other diseases insurance companies might be inclined to cover the cost of a test for, such as lung cancer.
If successful, it could be used not just in homes, but for mass detection of diseases and pathogens in public spaces.
“Telehealth is growing,” Agabi said. “Our goal is not another Zoom application, but to actually bring technology closer to people to be able to screen disease in real time.”
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) secured a record 70.2 percent share of the global foundry business in the second quarter, up from 67.6 percent the previous quarter, and continued widening its lead over second-placed Samsung Electronics Co, TrendForce Corp (集邦科技) said on Monday. TSMC posted US$30.24 billion in sales in the April-to-June period, up 18.5 percent from the previous quarter, driven by major smartphone customers entering their ramp-up cycle and robust demand for artificial intelligence chips, laptops and PCs, which boosted wafer shipments and average selling prices, TrendForce said in a report. Samsung’s sales also grew in the second quarter, up
On Tuesday, US President Donald Trump weighed in on a pressing national issue: The rebranding of a restaurant chain. Last week, Cracker Barrel, a Tennessee company whose nationwide locations lean heavily on a cozy, old-timey aesthetic — “rocking chairs on the porch, a warm fire in the hearth, peg games on the table” — announced it was updating its logo. Uncle Herschel, the man who once appeared next to the letters with a barrel, was gone. It sparked ire on the right, with Donald Trump Jr leading a charge against the rebranding: “WTF is wrong with Cracker Barrel?!” Later, Trump Sr weighed
HEADWINDS: Upfront investment is unavoidable in the merger, but cost savings would materialize over time, TS Financial Holding Co president Welch Lin said TS Financial Holding Co (台新新光金控) said it would take about two years before the benefits of its merger with Shin Kong Financial Holding Co (新光金控) become evident, as the group prioritizes the consolidation of its major subsidiaries. “The group’s priority is to complete the consolidation of different subsidiaries,” Welch Lin (林維俊), president of the nation’s fourth-largest financial conglomerate by assets, told reporters during its first earnings briefing since the merger took effect on July 24. The asset management units are scheduled to merge in November, followed by life insurance in January next year and securities operations in April, Lin said. Banking integration,
LIMITED IMPACT: Investor confidence was likely sustained by its relatively small exposure to the Chinese market, as only less advanced chips are made in Nanjing Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) saw its stock price close steady yesterday in a sign that the loss of the validated end user (VEU) status for its Nanjing, China, fab should have a mild impact on the world’s biggest contract chipmaker financially and technologically. Media reports about the waiver loss sent TSMC down 1.29 percent during the early trading session yesterday, but the stock soon regained strength and ended at NT$1,160, unchanged from Tuesday. Investors’ confidence in TSMC was likely built on its relatively small exposure to the Chinese market, as Chinese customers contributed about 9 percent to TSMC’s revenue last
RSS